O OLEMA PHARMACEUTICALS INC
| Market Cap | $1.31B |
| P/E Ratio | — |
| Forward P/E | -5.92 |
| Dividend Yield | — |
| Beta | 2.18 |
| 52W Range | $3.06 - $35.83 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $380.00K | 15,206 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 24 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 233 | $24.69 | $5.75K | 04 Mar 2026 | 05 Mar 2026 |
| Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 24,767 | $24.25 | $600.60K | 04 Mar 2026 | 05 Mar 2026 |
| Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 15,000 | $23.01 | $345.15K | 03 Mar 2026 | 05 Mar 2026 |
| Harmon Cyrus | Sale | 10,000 | $26.88 | $268.80K | 20 Jan 2026 | 21 Jan 2026 |
| Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Sale | 100,000 | $28.73 | $2.87M | 15 Jan 2026 | 15 Jan 2026 |
| Harmon Cyrus | Sale | 3,489 | $29.12 | $101.60K | 14 Jan 2026 | 16 Jan 2026 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 35,003 | $28.99 | $1.01M | 14 Jan 2026 | 14 Jan 2026 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 14,997 | $28.60 | $428.91K | 14 Jan 2026 | 14 Jan 2026 |
| Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Sale | 3,822 | $28.01 | $107.05K | 13 Jan 2026 | 15 Jan 2026 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 200 | $28.49 | $5.70K | 13 Jan 2026 | 14 Jan 2026 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 49,800 | $27.60 | $1.37M | 13 Jan 2026 | 14 Jan 2026 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 10,000 | $28.34 | $283.40K | 12 Jan 2026 | 14 Jan 2026 |
| Zojwalla NaseemChief Medical Officer | Sale | 99,509 | $27.66 | $2.75M | 23 Dec 2025 | 23 Dec 2025 |
| Zojwalla NaseemChief Medical Officer | Sale | 100,000 | $28.04 | $2.80M | 22 Dec 2025 | 23 Dec 2025 |
| Harmon Cyrus | Sale | 2,881 | $28.53 | $82.19K | 22 Dec 2025 | 29 Dec 2025 |
| Cyrus HarmonDirector | Sale | 2,881 | $28.53 | $82.19K | 22 Dec 2025 | 29 Dec 2025 |
| Zojwalla NaseemChief Medical Officer | Sale | 12,921 | $28.93 | $373.80K | 19 Dec 2025 | 23 Dec 2025 |
| CLARK IAN T | Sale | 41,840 | $30.48 | $1.28M | 19 Dec 2025 | 23 Dec 2025 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 6,046 | $31.39 | $189.78K | 19 Dec 2025 | 23 Dec 2025 |
| Zojwalla NaseemChief Medical Officer | Sale | 57,079 | $28.03 | $1.60M | 19 Dec 2025 | 23 Dec 2025 |
| CLARK IAN T | Sale | 193,056 | $29.71 | $5.74M | 19 Dec 2025 | 23 Dec 2025 |
| CLARK IAN T | Sale | 29,904 | $28.83 | $862.13K | 19 Dec 2025 | 23 Dec 2025 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 43,729 | $30.40 | $1.33M | 19 Dec 2025 | 23 Dec 2025 |
| Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 | $28.08 | $34.40K | 19 Dec 2025 | 23 Dec 2025 |
Frequently Asked Questions
What is OLMA stock price today?
OLEMA PHARMACEUTICALS INC (OLMA) is currently trading at $15.06. The stock has a 52-week range of $3.06 to $35.83 and a market capitalization of $1.31B.
Is OLMA a good stock to buy in 2026?
OLEMA PHARMACEUTICALS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +349.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling OLMA stock?
There have been 24 insider transactions for OLMA in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has OLMA stock performed over the past year?
OLEMA PHARMACEUTICALS INC (OLMA) has returned +349.6% over the past 12 months. The stock traded between $3.06 and $35.83 during this period, and is currently at $15.06.
Which hedge funds own OLMA (OLEMA PHARMACEUTICALS INC)?
1 tracked hedge funds currently hold OLMA in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is OLMA's market cap and valuation?
OLEMA PHARMACEUTICALS INC (OLMA) has a market capitalization of $1.31B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is OLMA's revenue and profitability?
OLEMA PHARMACEUTICALS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 2.18.
What sector is OLMA in and who are its biggest institutional holders?
OLEMA PHARMACEUTICALS INC (OLMA) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.